ADA 2023: Retatrutide Reduces Body Weight Up to 17 Percent at 36 Weeks in Patients With Type 2 Diabetes
The medication also leads to improved glycemic control and shows favorable safety profile
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.